Safety and Efficacy of Immune Checkpoint Inhibitors Plus Bacillus Calmette–Guérin for High-Risk Non–Muscle-Invasive Bladder Cancer: A Bayesian Re-analysis of a Published Frequentist Meta-analysis

Clinical Genitourinary Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles